MedTrace Logo

TDN, Manual Therapy and Exercise For the Management of Achilles Tendinopathy

NCT02532595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-06-30

No results posted yet for this study

Summary

Conflicting evidence exists regarding the recommendations from the Orthopaedic section of the American Physical Therapy Association for treatment of Achilles tendinitis. Trigger point dry needling is effective in reducing pain in several body regions, but no published (TDN) studies are found reporting the effect on Achilles tendinopathy. The purpose of this study is to investigate whether a treatment program performed including TDN, manual therapy and exercise will result in a significant improvement in pain, strength and function compared to a treatment program including manual therapy and exercise for Achilles tendinopathy. Subjects with Achilles tendinopathy that receive treatment including TDN, manual therapy and exercise will demonstrate a significant improvement in pain, strength and functional outcomes compared to the group that receives manual therapy and exercise.

Conditions

  • Achilles Tendon Injury

Interventions

PROCEDURE

manual therapy and exercise

soft tissue mobilization, stretches, concentric and eccentric strengthening

PROCEDURE

trigger point dry needling

trigger point dry needling to trigger points located in the gastrocnemius, soleus and tibialis posterior

Sponsors & Collaborators

  • Nova Southeastern University

    lead OTHER

Principal Investigators

  • Josh Cleland, DPT, PhD · Nova Southeastern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02532595 on ClinicalTrials.gov